A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors 
Brooklyn ImmunoTherapeutics Welcomes Dr. Kevin A. D’Amour as Chief Scientific Officer
BROOKLYN, N.Y., June 08, 2021 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NYSE American: BTX) ("Brooklyn"), a biopharmaceutical company focused on...
ProMIS Neurosciences congratulates Biogen on FDA accelerated approval of aducanumab for Alzheimer’s disease
Approval of aducanumab offers real hope for patients and fuels development of next-generation therapies with more selective binding for toxic...
ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease
First Ever Stem Cell Clinical Trial Patient Treated Using Entire ClearPoint Platform ClearPoint Neuro ClearPoint Neuro Navigation Platform for Drug...
Qualigen Therapeutics Announces Inclusion in Russell Microcap® Index
CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing novel...
Aurora Spine Corporation to Present at the Lytham Partners Summer 2021 Investor Conference
CARLSBAD, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF),...
MediPharm Labs Extends Strategic Partnership with ADREXpharma and continues to Build its Presence in Germany
MediPharm and ADREXpharma continue to lead the way addressing rising patient demand in the burgeoning German Medical Cannabis Market that...
AzurRx BioPharma CEO James Sapirstein to Present at 2021 BIO Digital
BOCA RATON, Fla., June 08, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical...
Vaccinex Announces Activation of Clinical Sites to Enroll Patients in Studies of Pepinemab as Single Agent in Alzheimer’s Disease and in Combination with KEYTRUDA® in Advanced, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
Company plans to activate at least 13 clinical sites for Alzheimer’s study and 18 clinical sites for head and neck...
Baudax Bio’s ANJESO® Achieves Formulary Listing at Over 100 Institutions in Less Than One Year on the Market
MALVERN, Pa., June 08, 2021 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company focused on developing and commercializing...
Jushi Holdings Inc. Announced its Subsidiary, Franklin Bioscience – NE LLC, Will Open Its 20th BEYOND / HELLO™ Retail Location Nationwide with 13th Store in Pennsylvania
BEYOND / HELLO™ Easton Inside Photo BEYOND / HELLO™ Easton, which is located at 3812 Easton-Nazareth Highway Rd. in the...
Amicus Therapeutics Announces United Kingdom’s MHRA Grants Early Access to AT-GAA
Permits All Eligible Individuals with Late-Onset Pompe Disease Access to AT-GAA Prior to Marketing Authorization in the UK Positive Scientific...
Odyssey Group International to Present at LD Micro Virtual Investor Conference
IRVINE, CA, June 08, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY) (the "Company" or "Odyssey"), a technology and...
BioAdaptives Commences Social Media Roll-Out
Targets markets for pain relief and anti-viral/immune defense applications Las Vegas, Nevada, June 08, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire...
Anavex Life Sciences Announces Exceeding of Enrollment Target for the Precision Medicine ANAVEX®2-73 (blarcamesine) Phase 2b/3 Clinical Trial in Patients with Alzheimer’s Disease
NEW YORK, June 08, 2021 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
Summit Therapeutics set to join Russell 3000® Index
Cambridge, MA, June 08, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) is set to join the broad-market Russell...
Rockwell Medical and Drogsan Pharmaceuticals Enter into Exclusive License Agreement for the Rights to Commercialize Triferic® in Turkey
- With approximately 65,000 patients receiving hemodialysis annually, Turkey represents a significant and expanding market opportunity -WIXOM, Mich. and ANKARA,...
COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences
LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating...
Foghorn Therapeutics to Host Research & Development Day Webinar on June 15th
CAMBRIDGE, Mass., June 08, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
CarePort® Introduces CarePort Quality Score to Measure SNF Performance for Short-Stay Patients
New ranking system for SNF quality of care helps discharge planners and case managers guide patient decision-making during the discharge...
Glaukos Announces Australia’s TGA Regulatory Approval for PRESERFLO™ MicroShunt
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the...